Teladoc Appoints Former CEO of Allina Health Ken Paulus to Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Teladoc (TDOC) PT Raised to $27 at Oppenheimer Following 4Q Report
March 2, 2017 9:22 AM ESTOppenheimer raised its price target on Teladoc (NYSE: TDOC) to $27.00 (from $23.00) while maintaining a Outperform rating. TDOC reported Q4 revenues of $37.4M vs. consensus' $36.8M. Adjusted EPS loss in Q4 was ($0.31) vs. consensus' ($0.34) estimate.
Analyst Mohan Naidu commented, "TDOC's Q416 results and... More
